Clinical trial services have adapted to post-pandemic reality with accelerated innovation in trial approaches, virtual technologies and decentralization. What can we expect this year and what will the implications be?
Watch this on-demand webinar to find out!
Chris Baker, President at ICON, Symphony Health and Jon Shephard, Partner at PwC, Deals & Strategy, share their insights based on years of experience working with and advising investors and the largest players in the industry.
Get a unique opportunity to get insight into the state of clinical trials from Chris and Jon at this online event hosted by the Co-founder and CEO at Arbolus, Sam Glasswell.
President at ICON, Symphony Health and former Executive VP and Global Head of Parexel FSP.
Our speakers have extensive experience working with the world's largest CRO companies and advising clinical trials investors on all aspects of strategy, M&A, and due diligence. Drawing from their deep expertise, Chris and Jon will help you:
Investors
Strategy consultants
Clinical research professionals
Marketers
Life Sciences interested
Arbolus is a knowledge-sharing platform that connects businesses with top industry professionals and provides more efficient, convenient and accessible ways to gather and share insights.
Watch now and gain invaluable insight into the state of clinical trials in 2023.